NCT06105645

Brief Summary

The main aim of this study is to evaluate the contribution of fast-ripples (FR) information on the neurosurgery management of patients with drug-refractory epilepsy investigated by Stereo-ElectroEncephaloGraphy (SEEG), as measured by freedom from disabling seizures one-year post-surgery. 220 patients (for whom 4-6 usual clinical macro-electrodes will be replaced by hybrid micro-macro electrodes and for whom fast-ripples will be assessed) distributed over 5 centres and 220 control patients(who will undergo an SEEG with the usual electrodes and for whom fast-ripples will not be assessed) distributed over 6 centres. This is a controlled, non-randomized, parallel plan, prospective, multicentre exploratory study.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
440

participants targeted

Target at P75+ for not_applicable

Timeline
47mo left

Started Jan 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

11 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress37%
Jan 2024Apr 2030

First Submitted

Initial submission to the registry

October 23, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 27, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

January 19, 2024

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2030

Last Updated

September 22, 2025

Status Verified

September 1, 2025

Enrollment Period

6.2 years

First QC Date

October 23, 2023

Last Update Submit

September 17, 2025

Conditions

Keywords

Fast-ripplesEpilepsyNeurosurgeryHybrid electrodesMICRODEEP® MME hybrid electrodesStereoEEG

Outcome Measures

Primary Outcomes (1)

  • Contribution of fast-ripples information on freedom seizures

    Proportion of patients with Engel class I after one-year post-surgery in the group of patients with information of fast-ripples compared to patients without.

    12 months after epilepsy surgery

Secondary Outcomes (11)

  • Contribution of fast-ripples information on improvement of epilepsy

    12 months after epilepsy surgery

  • Contribution of fast-ripples information on patients addressed to neurosurgery

    12 months after epilepsy surgery

  • Adverse effects related to Stereo-electroencephalography

    Day 0 (SEEG visit)

  • Adverse effects of epilepsy surgery

    6 months after surgical decision

  • Adverse effects of hybrid electrodes

    Day 0 (SEEG visit)

  • +6 more secondary outcomes

Study Arms (2)

Arm with fast-ripples information

EXPERIMENTAL

Patients for whom 4-6 usual clinical macro-electrodes will be replaced by hybrid micro-macro electrodes and for whom fast-ripples will be assessed

Device: DIXI Medical Microdeep® Micro- Macro Depth electrodes

Arm without fast-ripples information

ACTIVE COMPARATOR

Patients who will undergo an SEEG with the usual electrodes and for whom fast-ripples will not be assessed.

Device: Standard electrodes

Interventions

It is a deep intracerebral electrode used in the pre-surgical diagnosis of certain drug-resistant epilepsies. It consists of micro- and macro-contacts and is designed for Stereo-ElectroEncephalography (SEEG) recording via the macro-contacts or micro-contacts and brief stimulation via the macro-contacts.

Arm with fast-ripples information

Standard electrodes used usually during the SEEG

Arm without fast-ripples information

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient suffering from drug-resistant focal epilepsy (DRFE), as defined by the International League Against Epilepsy, undergoing SEEG, the indication of which was selected during a multidisciplinary epilepsy meeting
  • Patient who has given written informed consent to allow the study data collection procedures
  • Patient covered by the French healthcare system.

You may not qualify if:

  • Patients under juridical protection (authorship, curators or safeguarding of justice).
  • Patient deprived of liberty by a judicial or administrative decision
  • Patient with a cardiac defibrillator
  • Thermocoagulation planned on one of the potential hybrid electrodes .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (11)

CHU Amiens Picardie

Amiens, France

RECRUITING

University hospital of Bordeaux

Bordeaux, 33076, France

RECRUITING

University hospital of Grenoble Alpes

La Tronche, 38700, France

RECRUITING

APHP Hôpital Bicêtre

Le Kremlin-Bicêtre, 94270, France

RECRUITING

CHU de Lille

Lille, France

RECRUITING

Hospices Civils de Lyon

Lyon, France

RECRUITING

CHRU de Nancy

Nancy, France

RECRUITING

Fondation Adolphe de Rothschild

Paris, 75019, France

NOT YET RECRUITING

CHU de Rennes

Rennes, France

RECRUITING

Hôpitaux universitaires de Strasbourg

Strasbourg, France

RECRUITING

University Hospital of Toulouse

Toulouse, 31059, France

RECRUITING

Related Publications (1)

  • Despouy E, Curot J, Reddy L, Nowak LG, Deudon M, Sol JC, Lotterie JA, Denuelle M, Maziz A, Bergaud C, Thorpe SJ, Valton L, Barbeau EJ. Recording local field potential and neuronal activity with tetrodes in epileptic patients. J Neurosci Methods. 2020 Jul 15;341:108759. doi: 10.1016/j.jneumeth.2020.108759. Epub 2020 May 7.

    PMID: 32389603BACKGROUND

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Luc VALTON, MD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yoan HERADES

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2023

First Posted

October 27, 2023

Study Start

January 19, 2024

Primary Completion (Estimated)

April 1, 2030

Study Completion (Estimated)

April 1, 2030

Last Updated

September 22, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations